This compound is a pharmaceutical intermediate designed as a DOTA-based bioconjugation building block. It features a maleimide group for selective coupling with thiol-containing biomolecules and multiple tert-butyl ester-protected carboxyl groups, enabling controlled deprotection and conjugation in research and manufacturing settings.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1613382-10-7
Methyl 4-aminopyridine-3-carboxylate
pharmaceutical intermediate
1-Methanesulfonylpiperazine hydrochloride
pharmaceutical intermediate
(3S)-3-hydroxy-L-lysine
pharmaceutical intermediate
1-(4-fluorophenyl)piperazine hydrochloride
Pharmaceutical intermediate
DOTA-maleimido
bioconjugation reagent for targeted imaging
tert-butyl 2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethylamino]-2-oxoethyl]-7,10-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetate
AWBZYCMDPJWQKQ-UHFFFAOYSA-N
CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(=O)NCCN2C(=O)C=CC2=O
—